Analyst Opinions

Aarti Drugs posts 16% PAT growth, new MD takes charge

Jio Platforms Lists at 21% Premium, What's Next?

Jio Platforms (

Daily Index View : NIFTY50 as on 28/10/2026

1. Market Trend PROBABILITY 🚨 Current Market Trend: Positive 🚀 -5% 🔍 Key Level to Watch: 22659 🔄 Current Market Surface: The trend will stay Positive until the market stay above 22659 That’s 91 points away from the last day… See Moremore

HINDUSTAN UNILEVER Q2 FY27 : SEGMENT-WISE PERFORMANCE

HINDUSTAN UNILEVER Q2 FY27 : SEGMENT-WISE PERFORMANCE

CRUDE OIL AND THE FED REMAIN KEY TRIGGERS

RailTel's ₹20.04 crore order adds to its contract pipeline

RailTel Corporation of India Limited (NSE: RAILTEL) has received an order worth ₹20.04 crore, including tax, from Munitions India Limited. The project is scheduled to go live within four months, by 28 February 2027. The order adds to RailT… See Moremore

Larsen & Toubro reports 33% quarterly profit growth

Larsen & Toubro

Subros wins massive heating and cooling contract from MSIL.

Subros Limited secured a fresh automotive component supply award from Maruti Suzuki India Limited on October 28, 2026. The thermal system contract holds a total life cycle valuation of approximately ₹1,225 crore. Body Subros Limited disclos… See Moremore

United Breweries Limited (UBL) has reported a blockbuster Q2

United Breweries Q2 Profit Jumps 191% on Premium Sales

🚨 BAJEL PROJECTS WINS ₹1,500 CRORE TRANSMISSION ORDER! ⚡

Bajel Projects Limited has secured an EPC order worth approximately ₹1,500 crore, including GST, from Lakadia A Power Transmission Limited to strengthen electricity transmission infrastructure supporting renewable-energy evacuation in Gujar… See Moremore

Sensex, Bankex analysis for 28/10/2026 (MARKET ANALYSIS)

1. Sensex Analysis Current Index Level: 73,598 Key Pivot / Support Threshold: 72,900 Trading Strategy & Technical Stance: Current Position: Hold Long (Bullish Bias) Rationale: As long as Sensex trades and sustains above 72,900, the struc… See Moremore

Piramal Pharma Q2 revenue rises 28.43% to ₹2,620 crore

Piramal Pharma Limited (NSE: PPLPHARMA)

Nifty at 22,750 Trendline Resistance; BSE Clears Resistance

Yesterday’s expiry session was volatile. Nifty opened higher and reached a high near 22,830, just short of 22,872. It then corrected into the 22,690-22,570 pivot cluster, recovered and settled near 22,760. It now faces a falling trendline n… See Moremore

India’s Cybersecurity Wake-Up Call: Who Benefits?

Imagine visiting your bank’s website. How do you know it’s genuine and not a fake website stealing your money? The internet uses digital certificates like identity cards to prove that websites are genuine. But what happens when the company… See Moremore

GIFT NIFTY SIGNALS SHARP GAP-DOWN | FIIs BUY ₹4,240 CRORE..

PRE-MARKET REPORT | 28 OCTOBER 2026 GIFT NIFTY SIGNALS SHARP GAP-DOWN | FIIs BUY ₹4,240 CRORE | BANK NIFTY SUPPORT AT 53,700–54,000 Market Outlook: Cautious Opening | Stock-Specific Opportunities | Watch Crude Oil and Key Support Levels… See Moremore

STOCKS IN FOCUS TODAY | OCTOBER 28 - 2026

The market will be tracking fresh quarterly results, IPO listing action and company-specific developments today. Here are the stocks in focus and the key reasons behind them. POSITIVE CATALYSTS 1. Jio Platforms Jio Platforms is in focus a… See Moremore

Bajaj Auto Q2 profit rises 35% as revenue hits ₹20,003 crore

STOCKS IN NEWS: KEY STOCKS TO WATCH TODAY

Markets are expected to stay focused on earnings, corporate updates, and global cues. L&T could stay in the spotlight after strong profit growth, while Maruti Suzuki might see mixed reaction, because revenue improved but profitability dippe… See Moremore